Session Time: 1:45pm-3:15pm
Location: Hall 3FG
Objective: To study the changes of the expression of silent information adjustment factor 1 (SIRT1) and hypoxia inducing factor 1 (HIF-1) and changes in behavior in mice of MPTP treatment.
Background: Silent information adjustment factor 1 (SIRT1) and hypoxia inducing factor 1 (HIF1) were found to involve in the pathogenesis of Parkinson’s disease and plays an important role in disease progression.
Methods: To establish animal model of PD, MPTP was chose to treat C57BL6 mice, and then behavioral tests, HPLC and immunohistochemistry were conducted. Further, the levels of SIRT1 and HIF1- was detected.
Results: Mice in MPTP-treated group displayed a significant abnormal behavior , autonomic activity, gait and bradykinesia (all P<0．001). HPLC, which was used to investigate the levels of neurotransmitters, revealed decreased levels of DA and its metabolites (P<0．001) in MPTP-induced mice. MPTP reduced the levels of tyrosine hydroxylase (TH) and the dopamine transporter (DAT) remarkably (P<0．01), which are markers of substantia nigra dopaminergic neurons. At last, the expression levels of SIRT1 (P<0．05）was reduced and HIF1 (P<0．05） was increased in MPTP group compared with control group.
Conclusions: Abnormal behavior and decline of dopaminergic neurons markers prompted the successful establishment of PD model. The irregular expression of SIRT1/HIF – 1 in vivo supported our previous studies, and indicated that SIRT1 / HIF1 signaling may involve the disease process of PD.
To cite this abstract in AMA style:X.X. Cui, S.Y. Dong, Y.J. Guo, W.J. Zhao, Y.C. Wu. The change of SIRT1 and HIF-1 in MPTP treated mouse [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/the-change-of-sirt1-and-hif-1-in-mptp-treated-mouse/. Accessed December 11, 2023.
« Back to 2018 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/the-change-of-sirt1-and-hif-1-in-mptp-treated-mouse/